NCT05013775View on ClinicalTrials.gov

The Diagnostic Value of Staging Laparoscopy and Computed Tomography Response Assessment in Patients With Gastric Adenocarcinoma

CompletedOBSERVATIONAL
Enrollment

697

Participants

Timeline

Start Date

January 15, 2019

Primary Completion Date

August 22, 2020

Study Completion Date

May 12, 2021

Conditions
Gastric Cancer
Interventions
DIAGNOSTIC_TEST

Computed tomography

Computed tomography to gauge response after preoperative chemotherapy cycles and excluded the development of interval metastases or irresectable disease

DIAGNOSTIC_TEST

Diagnostic laparoscopy with peritoneal lavage

Diagnostic laparoscopy lavage to exclude (small-volume) metastases and determine local resectability

Trial Locations (1)

Unknown

Erasmus MC, Rotterdam

All Listed Sponsors
lead

Sander van Hootegem

OTHER

NCT05013775 - The Diagnostic Value of Staging Laparoscopy and Computed Tomography Response Assessment in Patients With Gastric Adenocarcinoma | Biotech Hunter | Biotech Hunter